Literature DB >> 28859604

Diagnosis, Management, and Outcome of Aortitis at a Single Center.

Nedaa Skeik1, Claire A Ostertag-Hill2, Ross F Garberich2, Peter B Alden3, Jason Q Alexander3, Andrew H Cragg3, Jesse M Manunga3, Elliot J Stephenson3, Jessica M Titus3, Timothy M Sullivan3.   

Abstract

BACKGROUND: Aortitis is a rare condition with inflammatory or infectious etiology that can be difficult to diagnose due to the highly variable clinical presentation and nonspecific symptoms. However, current literature on the diagnosis, management, and prognosis of aortitis is extremely scarce.
METHODS: We retrospectively reviewed all patients' charts who were diagnosed with giant cell arteritis, Takayasu arteritis, or noninfectious aortitis presenting at a single center between January 1, 2009, and April 17, 2015. Data collected included demographics, medical history, comorbidities, laboratory and imaging data, management, and outcome.
RESULTS: Among the included 15 patients presenting with aortitis at our center, 53% were diagnosed with Takayasu arteritis, 33% with idiopathic inflammatory aortitis, and 13% with giant cell arteritis. All patients received steroid treatment, 67% received adjunctive immunosuppressants or immunomodulators, and 33% underwent interventional procedures. Based on clinical presentation and laboratory and imaging findings at the last follow-up visit for each patient, 67% showed improvement, 27% had no change in disease activity, and 7% had a progression of the disease.
CONCLUSIONS: Takayasu arteritis was found to be more common than idiopathic inflammatory aortitis and giant cell arteritis among our 15 cases diagnosed with aortitis. All patients received medical therapy and 33% received interventional procedures, leading to 67% improvement of disease activity or related complications. This article also offers a comprehensive review of the diagnosis, management, and outcome of aortitis, supplementing the very limited literature on this disease.

Entities:  

Keywords:  aorta; aortic diseases; vasculitis

Mesh:

Substances:

Year:  2017        PMID: 28859604     DOI: 10.1177/1538574417704296

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  3 in total

1.  Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis.

Authors:  Chunling Wu; Ying Sun; Xiaomeng Cui; Sifan Wu; Lili Ma; Huiyong Chen; Yan Yan; Zongfei Ji; Yun Liu; Jiang Lin; Peng Lv; Rongyi Chen; Pingting Yang; Lindi Jiang
Journal:  Ther Adv Chronic Dis       Date:  2020-11-29       Impact factor: 5.091

Review 2.  Mechanism and biomarkers in aortitis--a review.

Authors:  Benjamin Benhuri; Ammar ELJack; Bashar Kahaleh; Ritu Chakravarti
Journal:  J Mol Med (Berl)       Date:  2019-10-30       Impact factor: 4.599

3.  Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study.

Authors:  Sun Ying; Cui Xiaomeng; Dai Xiaomin; Lin Jiang; Lv Peng; Ma Lili; Chen Rongyi; Ji Zongfei; Chen Huiyong; Jiang Lindi
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-06-02       Impact factor: 5.346

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.